Skip to content

Saya Ennai In The Management Of Eraippu Noi (Bronchial Asthma)

An Open Non-Randomised Single Arm Single Centric Clinical Trial To Evaluate The Effectiveness Of Saya Ennai In The Management Of Eraippu Noi (Bronchial Asthma)Among Out-Patients Attending Ayothidoss Pandithar Hospital,NIS

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040620
Enrollment
30
Registered
2022-02-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

Intervention1: SAYA ENNAI: Dosage: 2 ml (2 kaasedai) by using filler twice a day after food Duration of treatment : 48Days Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18-60years. Sex: Male ,Female &Transgender. Patients with clinical symptoms of Sneezing, Rhinitis, Dyspnea, Cough with or without expectoration, Wheeze, Tightness of chest. (Any of the above 5 symptoms would be present daily or twice or thrice in a week) Patients who are willing to undergo Pulmonary Function Tests, radiological investigations and provide blood sample for lab investigations.

Exclusion criteria

Exclusion criteria: Having covid -19 (or) recent history of covid -19 infection K/H/O other Lung diseases K/H/O Cardiac diseases and Renal diseases Sleep Apnea Pregnancy Lactation.

Design outcomes

Primary

MeasureTime frame
PRIMARY OUTCOME: 1.Primary outcome is assessed by comparing the lung volumes and capacities in pulmonary function tests along with graph PFT of obstructive pattern before and after treatment. Timepoint: 49th day

Secondary

MeasureTime frame
SECONDARY OUTCOME: 1.Secondary outcome is assessed by comparing the improvement of clinical symptoms of Eraippu noi patients and laboratory parameters such as IgE, Absolute Eosinophil Count (AEC) before and after treatment.2.Quality of life in Eraippu noi (Bronchial Asthma) patients is assessed through Asthma Quality of Life Questionairre (AQLQ)Timepoint: 49th day

Countries

India

Contacts

Public ContactDr K Bharathy

National Institute of Siddha Tambaram Sanatorium

drlakshmiramaswamy@gmail.com9444466880

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026